OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Economics
181 Publications
found
Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer.
b
Lung cancer (Amsterdam, Netherlands)
October 1, 2018
p
Cancer
c
Economics
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
b
BMC health services research
August 6, 2018
p
Preeclampsia
c
Economics
Model
Economic evaluation of sFlt-1/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals.
b
Pregnancy hypertension
July 1, 2018
p
Preeclampsia
c
Economics
Model
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
b
BMC cancer
June 27, 2018
p
Cancer
c
Economics
Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial.
b
JAMA internal medicine
February 1, 2018
p
Cardiovascular Disease
c
Change patient management
Clinical outcomes
Economics
Operational efficiencies
RCT
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China.
b
PloS one
January 1, 2018
p
Cancer
c
Economics
Model
Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health.
b
PloS one
January 1, 2018
p
HIV POCT
c
Cluster RCT
Economics
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.
b
JCO precision oncology
January 1, 2018
p
Cancer
c
Change patient management
Clinical outcomes
Economics
Observational
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
b
Journal of medical economics
November 1, 2017
p
Diabetes
c
Change patient management
Economics
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
b
AIDS (London, England)
September 24, 2017
p
HIV POCT
c
Economics
Model
Previous Page
1
…
10
11
12
13
14
…
19
Next Page
